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Got Oxygen for Tumors?
PAGE 839
Tumors stimulate angiogenesis for their nourishment. Paradoxically, they release
excessive amounts of angiogenic factors, leading to formation of tumor blood vessels
with abnormal morphology that impairs tumor perfusion and oxygenation. In this
issue, Mazzone et al. show that blood vessels have built-in mechanisms to readjust
oxygen delivery in the event of hypoxia. Reduced activity of the oxygen sensor
PHD2 under hypoxic conditions induces endothelial normalization, thereby improving
tumor perfusion and oxygenation. This change in blood vessel morphology and endo-
thelial shape suffices to induce a shift to a more benign tumor behavior and to prevent
metastasis. Improved tumor oxygenation also has implications for increased efficacy
of chemotherapeutic treatments.
In Replication, It’s First Come, First Served
PAGE 852
In eukaryotic cells, accurate duplication of the genome occurs prior to each round of division and relies on the coordinated
utilization of origins of replication. Origins fire at characteristic times during S phase, and Wu and Nurse investigate this
temporal program of DNA duplication. Perturbation of origin binding by the origin recognition complex, the length of M phase,
or the levels of replication initiation proteins results in genome-wide modifications in the timing and efficiency of origin usage.
The data suggest a model in which the timing of origin firing correlates with the timing of replication factor binding during
mitosis and the efficiency of origin firing depends on subsequent competition for replication factors.
Ndc80’s Feats of Strength
PAGE 865
Duringmitosis, kinetochores link chromosomes to the tips of dynamic spindle microtubules (MTs), allowing these filaments to
exert the force needed to move chromosomes. Powers et al. demonstrate that Ndc80, a core kinetochore component that is
required for microtubule coupling in vivo, forms load-bearing attachments to both assembling and disassembling MT tips
in vitro. Ensemble, single-molecule, and computational results are all consistent with a coupling mechanism based on biased
diffusion that allows kinetochores to track both assembling and disassembling MT tips. This potentially general mechanism
suggests a strategy by which the connection between chromosomes and MTs in eukaryotes can be maintained even as MTs
undergo dynamic changes in length.
Direct STIMulation of CRAC Channel Opening
PAGE 876
Store-operated calcium channels play essential roles in signaling during immune
activation and other cell functions. An ER-resident protein, STIM1, senses calcium
depletion in the ER lumen and transmits that information to open calcium-selective
CRAC channels in the plasma membrane. Park et al. now identify a cytosolic
‘‘CRAC activation domain’’ in STIM1 that binds directly to Orai1, a structural
component of the CRAC channel, to elicit both channel clustering and opening.
These results describe the final activation step in store-operated calcium entry
and explain how STIM1 in the ER at ER-plasma membrane junctions activates
the highly mobile CRAC channel at the cell surface.
TANGO Dumps Its Partner in COPII Vesicles
PAGE 891
A vast number of diverse cargos are exported from the endoplasmic reticulum (ER) into COPII-coated transport vesicles. How-
ever, onlya fewcargo-specific receptorshavebeen identified.Here,Saitoetal. provideevidence thatTANGO1,an integralmem-
braneprotein that localizes toERexit sites, is required for theexport of collagenVII. TANGO1binds tocollagenVII in theER lumen
and toCOPII components on the cytoplasmic side andappears to guide cargo into theCOPII carrier. Unlikepreviously identified
receptors that are loaded into the COPII carrier along with the cargo, TANGO1 dissociates from both the cargo and COPII
components upon completion of cargo loading. Thus, TANGO1 represents a unique facilitator of COPII vesicle cargo loading.Cell 136, March 6, 2009 ª2009 Elsevier Inc. 795
Asclerating Intestinal Stem Cell Growth
PAGE 903
The intestinal epithelium is the most rapidly self-renewing tissue of mammals. It is fueled
by a long-lived pool of rapidly cycling stem cells defined by Lgr5 expression. Van der Flier
et al. have now uncovered a small group of genes uniquely expressed in Lgr5 stem cells,
including the transcription factor Ascl2. Transgenic expression of Ascl2 throughout the
intestinal epithelium induces crypt hyperplasia and ectopic crypts on villi. Induced dele-
tion of Ascl2 in the adult intestine leads to disappearance of Lgr5 stem cells within days.
The authors conclude that whereas Lgr5marks intestinal stem cells, Ascl2 controls their
cell fate.
A Phosphatase Comes on Stage in Insulin Signaling
PAGE 939
The conserved insulin/IGF-1 signaling (IIS) pathway plays a central role in the regulation of life span, development, andmetab-
olism. Although the major regulatory control of IIS is via phosphorylation by serine/threonine kinases, little is known about the
phosphatases that counterbalance this pathway. Here, Padmanabhan et al. find that inC. elegans, PPTR-1, a PP2A regulatory
subunit, modulates IIS by negatively regulating AKT-1 phosphorylation. This modulation ultimately results in the increased
activity of the forkhead transcription factor DAF-16 and upregulation of genes required for increased longevity and stress
resistance. The authors further show that mammalian PPTR-1/B56 can also regulate Akt phosphorylation. This study may
have implications for age-associated diseases such as cancer and Type 2 Diabetes where IIS is dysregulated.
A Family of miRNA Boosters
PAGE 913 and PAGE 926
TRIM-NHL proteins represent a large class of metazoan proteins implicated in the regulation of cell
proliferation and development. Two studies in this issue now demonstrate that members of this
protein family—TRIM32 in mice and NHL-2 in worms—act as positive regulators of microRNA func-
tion. Schwamborn et al. show that during asymmetric cell division in mouse neural progenitor cells,
TRIM32 is enriched in one of the two daughter cells. After division, TRIM32 regulates both degrada-
tion of c-Myc as well as the activity of the microRNA let-7 to induce cell-cycle exit and neuronal
differentiation. Hammell et al. show that NHL-2 physically associates with miRISC and a critical
component of cytoplasmic processing bodies, CGH-1. The authors propose that the NHL-2-CGH-1
complex, in association with mature miRISC, modulates the efficacy of microRNA:target interactions
in response tophysiological anddevelopmental signals, therebyensuring the robustnessof pathways regulatedbymicroRNAs.
Connecting the Dots in Phosphorylation
PAGE 952
The regulation of phosphorylation impinges on all cellular processes. Using an E-MAP approach, Fiedler et al. carry out
a comprehensive genetic analysis of factors involved in this regulation in budding yeast, including kinases and phosphatases
that act on proteins and small molecules. The data reveal a network enriched for linear pathways of regulation, consistent with
successive phosphorylation and dephosphorylation activities. Beyond recapitulating known genetic interactions, this
approach links two kinases—Cak1 (involved in cell-cycle progression) and the MAP kinase Fus3—to a pathway that ensures
chromatin integrity during transcription by RNA polymerase II.
Freeing up iPS Cells from Viruses
PAGE 964
Induced pluripotent stem (iPS) cells derived from somatic cells of patients represent a powerful
tool for biomedical research andmay provide a source for replacement therapies. However, the
use of viruses encoding the reprogramming factors may interfere with the differentiation poten-
tial of the iPS cells or induce malignant transformation. Here, Soldner et al. derive Parkinson’s
disease patient-specific human iPS cells free of reprogramming factors usingCre-recombinase
excisable viruses. Global gene expression analysis of these factor-free iPS cells shows that
residual transgene expression in virus-carrying iPS cells can affect their molecular characteris-
tics, indicating that factor-free iPS cells may represent a more suitable source for the modeling
of human disease.Cell 136, March 6, 2009 ª2009 Elsevier Inc. 797
